L
Leigh A. Johnson
Researcher at University of North Texas Health Science Center
Publications - 106
Citations - 1898
Leigh A. Johnson is an academic researcher from University of North Texas Health Science Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 19, co-authored 74 publications receiving 1292 citations. Previous affiliations of Leigh A. Johnson include University of North Texas & Texas Tech University Health Sciences Center.
Papers
More filters
Journal ArticleDOI
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
Ganesh M. Babulal,Yakeel T. Quiroz,Benedict C. Albensi,Eider M. Arenaza-Urquijo,Arlene Astell,Arlene Astell,Claudio Babiloni,Alex Bahar-Fuchs,Joanne Bell,Gene L. Bowman,Gene L. Bowman,Adam M. Brickman,Gaël Chételat,Carrie Ciro,Ann D. Cohen,Peggye Dilworth-Anderson,Hiroko H. Dodge,Simone Dreux,Steven D. Edland,Anna J. Esbensen,Lisbeth Evered,Michael Ewers,Keith N. Fargo,Juan Fortea,Hector M. González,Deborah Gustafson,Elizabeth Head,James Hendrix,Scott M. Hofer,Leigh A. Johnson,Roos J. Jutten,Kerry Kilborn,Krista L. Lanctôt,Jennifer J. Manly,Ralph N. Martins,Michelle M. Mielke,Martha Clare Morris,Melissa E. Murray,Esther S. Oh,Mario A. Parra,Mario A. Parra,Robert A. Rissman,Catherine M. Roe,Octavio A. Santos,Nikolaos Scarmeas,Nikolaos Scarmeas,Lon S. Schneider,Nicole Schupf,Sietske A.M. Sikkes,Heather M. Snyder,Hamid R. Sohrabi,Yaakov Stern,Andre Strydom,Yi Tang,Graciela Muniz Terrera,Charlotte E. Teunissen,Debora Melo van Lent,Michael Weinborn,Linda M.P. Wesselman,Donna M. Wilcock,Henrik Zetterberg,Sid E. O'Bryant +61 more
TL;DR: A cross‐PIA white paper that provides both a concise “state‐of‐the‐science” report of ethnoracial factors across PIA foci and updated recommendations to address immediate needs to advance ADRD science across ethnorracial populations is synthesized.
Journal ArticleDOI
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
Sid E. O'Bryant,Michelle M. Mielke,Robert A. Rissman,Simone Lista,Simone Lista,Hugo Vanderstichele,Henrik Zetterberg,Piotr Lewczuk,Piotr Lewczuk,Holly Posner,James Hall,Leigh A. Johnson,Yiu-Lian Fong,Johan Luthman,Andreas Jeromin,Richard Batrla-Utermann,Alcibiades E. Villarreal,Gabrielle B. Britton,Peter J. Snyder,Kim Henriksen,Paula Grammas,Veer Bala Gupta,Ralph N. Martins,Harald Hampel,Harald Hampel +24 more
TL;DR: A collaborative model is proposed that leverages academic and industry strengths to facilitate the field in moving past discovery only work and toward clinical use and a new public‐private partnership model is intended to circumvent the traditional handoff model.
Journal ArticleDOI
Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease
Sidney O'Bryant,Leigh A. Johnson,Valerie Hobson Balldin,Melissa Edwards,Robert Barber,Benjamin F. Williams,Michael D. Devous,Blair Cushings,Janice Knebl,James Hall +9 more
TL;DR: The findings showed that Mexican Americans (normal controls, MCI, and AD) were younger, less highly educated, performed more poorly on the MMSE, endorsed more symptoms of depression, were more likely to be diagnosed with diabetes, and possessed the ApoE ε4 allele less frequently.
Journal ArticleDOI
Risk factors for mild cognitive impairment among Mexican Americans
Sidney O'Bryant,Leigh A. Johnson,Joan S. Reisch,Melissa Edwards,James Hall,Robert Barber,Michael D. Devous,Donald R. Royall,Donald R. Royall,Meharvan Singh +9 more
TL;DR: Although a great deal of literature has focused on risk factors for mild cognitive impairment (MCI), little published work examines risk for MCI among Mexican Americans.
Journal ArticleDOI
Biomarkers of Vascular Risk, Systemic Inflammation and Microvascular Pathology and Neuropsychiatric Symptoms in Alzheimer’s Disease
James Hall,April Wiechmann,Leigh A. Johnson,Melissa Edwards,Robert Barber,A. Scott Winter,Meharvan Singh,Sid E. O'Bryant +7 more
TL;DR: Gender differences suggest distinct impact of specific risks with total cholesterol, a measure of cardiovascular risk,being the strongest marker for males and IL-15, a marker of inflammation, being the strongest for females.